Fiscal Wizard · Single-issue tearsheet

ILMN / May 12, 2026 Run #8

ILMN

Illumina, Inc.

Diagnostics & Research

Composite verdict

A 77.0 / 100

Mixed fundamentals, strong technicals.

Industry rank 2nd of 14 in Diagnostics & Research

industry=Diagnostics & Research

Fundamentals Mixed

54.0 / 100

Score-bearing fundamentals shown here exclude gate-only risk checks. · 34 metrics shown.

Strongest
Weakest
EPS Growth (YoY) 100
Revenue Growth (YoY) 0
FCF Margin 100
Cash Conversion Cycle 0
EBITDA Margin 95
Inventory Turnover 7

Technicals Strong

100.0 / 100

Bullish setup leads (Fibonacci Retracement, MA Rejection, Sushi Roll); bears voided by gates. · 26 signals shown.

Strongest
Weakest
Fibonacci Retracement 100
Volume Climax 50
MA Rejection 91
52-Week Proximity 51
Declining Volume 89
OBV Divergence 72

Risk Gates

3 blocking 0 caution

3 gates blocking, 16 signals voided.

  • ADX Trend Weakness voids Trendline Break, Donchian Breakout +3
  • MA Crossover voids RSI Divergence, MACD Divergence +10
  • Regime Filter voids RSI Divergence, MACD Divergence +10

Breakdown

Look under the hood

Empty pane

Pick a category, above, to crack it open.

Every chip in either subscore card drills into the metrics or signals that fed it — including the formula, the threshold band, and what the current reading means for ILMN.